Maho Tsubota Selected Research

Maho Tsubota Research Topics

Disease

32	Hyperalgesia 06/2023 - 01/2013
29	Pain (Aches) 01/2024 - 01/2013
11	Visceral Pain 01/2023 - 04/2014
10	Peripheral Nervous System Diseases (PNS Diseases) 01/2024 - 01/2016
9	Cystitis 01/2023 - 04/2014
8	Hypersensitivity (Allergy) 01/2023 - 01/2016
8	Inflammation (Inflammations) 01/2023 - 11/2013
6	Pancreatitis 01/2023 - 01/2013
5	Neoplasms (Cancer) 01/2023 - 01/2018
3	Neuralgia (Stump Neuralgia) 01/2023 - 01/2018
3	Intractable Pain 12/2022 - 01/2018
3	Interstitial Cystitis (Interstitial Cystitis, Chronic) 06/2020 - 02/2015
3	Nociceptive Pain 01/2019 - 04/2014
3	Edema (Dropsy) 01/2018 - 04/2014
2	Multiple Myeloma 01/2021 - 01/2019
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 11/2020 - 05/2020
2	Disseminated Intravascular Coagulation 01/2019 - 11/2013
2	Hyperthermia 01/2017 - 01/2017
1	Hyperglycemia 01/2024
1	Type 2 Diabetes Mellitus (MODY) 01/2024
1	Wounds and Injuries (Trauma) 01/2023
1	Chronic Renal Insufficiency 01/2023
1	Catalepsy 12/2022
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 03/2022
1	Breast Neoplasms (Breast Cancer) 05/2021

Drug/Important Bio-Agent (IBA)

16	HMGB1 Protein (HMG1)IBA 01/2022 - 11/2013
12	ThrombomodulinIBA 05/2021 - 11/2013
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 04/2014
8	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2023 - 01/2018
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2016
6	CeruletideIBA 01/2023 - 01/2013
6	LyasesIBA 01/2023 - 02/2015
6	CystathionineIBA 01/2023 - 02/2015
6	Thrombin FDA Link 01/2021 - 04/2014
6	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 07/2019 - 01/2014
5	Protein Isoforms (Isoforms)IBA 12/2022 - 02/2015
5	Receptor for Advanced Glycation End ProductsIBA 01/2021 - 04/2014
5	Proteins (Proteins, Gene)FDA Link 12/2020 - 02/2015
4	ZincIBA 06/2023 - 02/2015
4	sodium sulfideIBA 01/2023 - 01/2016
4	Toll-Like Receptor 4IBA 01/2021 - 04/2014
4	Nuclear Proteins (Protein, Nuclear)IBA 01/2021 - 11/2013
4	Neutralizing AntibodiesIBA 12/2020 - 11/2013
4	sodium bisulfide (NaHS)IBA 01/2019 - 01/2014
4	LipopolysaccharidesIBA 01/2018 - 04/2014
3	GasotransmittersIBA 01/2023 - 01/2014
3	EnzymesIBA 01/2023 - 02/2015
3	Calcium Channels (Calcium Channel)IBA 01/2023 - 01/2018
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2022 - 01/2018
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2020 - 04/2014
3	Minocycline (Cyclops)FDA LinkGeneric 10/2018 - 01/2017
2	Chelating AgentsIBA 06/2023 - 01/2018
2	N,N,N',N'- tetrakis(2- pyridylmethyl)ethylenediamineIBA 06/2023 - 01/2018
2	Cysteine (L-Cysteine)FDA Link 01/2023 - 02/2016
2	Pimozide (Orap)FDA Link 12/2022 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2020
2	Butyrates (Butyrate)IBA 02/2021 - 11/2020
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021 - 01/2019
2	Bortezomib (Velcade)FDA Link 01/2021 - 01/2019
2	Dihydrotachysterol (AT 10)IBA 01/2021 - 01/2016
2	Substance PIBA 06/2020 - 01/2018
2	Calcineurin InhibitorsIBA 05/2020 - 01/2017
2	Tacrolimus (Prograf)FDA LinkGeneric 05/2020 - 01/2017
2	Capsaicin (Zostrix)FDA Link 05/2020 - 01/2014
2	CalcineurinIBA 05/2020 - 01/2017
2	Immunosuppressive Agents (Immunosuppressants)IBA 05/2020 - 01/2017
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2020 - 10/2018
2	AntioxidantsIBA 01/2020 - 02/2015
2	NNC 55-0396IBA 06/2019 - 02/2015
2	Dacarbazine (DIC)FDA LinkGeneric 01/2019 - 11/2013
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2019 - 02/2015
2	prolinedithiocarbamate (PDTC)IBA 10/2018 - 01/2018
2	Clodronic Acid (Clodronate)IBA 10/2018 - 12/2017
2	ethyl pyruvateIBA 10/2018 - 12/2017
2	ProstaglandinsIBA 01/2018 - 01/2017
2	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 01/2013
2	Alanine (L-Alanine)FDA Link 01/2018 - 01/2018
2	Analgesics (Analgesic Drugs)IBA 01/2016 - 11/2013
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2024
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2024
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 01/2024
1	Perindopril FDA LinkGeneric 01/2024
1	NAD (NADH)IBA 01/2024
1	Telmisartan (Micardis)FDA Link 01/2024
1	AngiotensinsIBA 01/2024
1	Angiotensin Receptor AntagonistsIBA 01/2024
1	3-(trihydroxygermyl)propanoic acidIBA 01/2023
1	GermaniumIBA 01/2023
1	Morphine (MS Contin)FDA LinkGeneric 01/2023
1	Sulfides (Thioethers)IBA 01/2023
1	SulfurIBA 01/2023
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 12/2022
1	Estrogens (Estrogen)FDA Link 05/2021
1	Bepridil (Vascor)FDA Link 01/2021
1	sym-trinitrobenzeneIBA 01/2021
1	Dopamine D2 Receptor AntagonistsIBA 01/2021
1	Sulfonic AcidsIBA 01/2021

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 03/2022 - 01/2016
2	Ligation 01/2018 - 01/2018
1	Therapeutics 05/2021